[Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].
Nakagawa
Masayuki
M
Department of Urology, Faculty of Medicine, Kagoshima University.
D000284:Administration, Oral; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D003864:Depression, Chemical; D004054:Diethylstilbestrol / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010902:Pituitary Gland / Q000502:physiology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013739:Testosterone / Q000378:metabolism; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D013739:Testosterone; D004054:Diethylstilbestrol; C004955:fosfestrol